News
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment By Annika Kim Constantino,CNBC • Published January 21, 2025 • Updated on January 21, 2025 at 11:04 am BOOKMARKER ...
The U.S. Food and Drug Administration has approved a ketamine-derivative nasal spray to treat depression. The medication is called eskatamine and it's developed by Johnson & Johnson subsidiary ...
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results